The Commission will present the state of play of the new EU AMR Action Plan, the EU's strategic approach to pharmaceuticals in the environment, supporting activities in developing countries, and funding opportunities under the Structural Reform Support Service (SRSS).
Interview of Prof. Panagiotis Behrakis, Project Coordinator of the Joint Action on Tobacco Control (JATC).
The conference on reducing health inequalities experienced by lesbian, gay, bisexual, transgendered and intersex (LGBTI) people aims to raise awareness of the challenges and the barriers both LGBTI people and health professionals face in accessing and providing health services.
Today the Commission has put forward a proposal to boost cooperation amongst EU Member States for assessing health technology. The strengthened cooperation is designed to improve timely access to the most innovative health technologies based on EU-level assessment of the added clinical value.
Today, the Commission publishes a report on the penalties EU countries apply to those involved in the production and circulation of falsified medicines.
The deadline for submission of proposals is 26 April 2018.
by Renate Krätke, Vice-Chair of the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER), Chair of the Working Group on Aluminium in Toys.
The Commission launches a public consultation on possible activities to be included in a proposal for stronger EU cooperation against vaccine preventable diseases, which will be adopted in 2018. Interested individuals and organisations are invited to have their say by 15 March 2018.
A report published today shows a sharp increase in organ donation and transplantation in the EU during the course of the 2009-2015 Action Plan. Between 2008 and 2015, the number of organ donors increased from 12 000 to nearly 15 000 (a 21% increase).
Today, the Commission sent an explanatory statement to Roche informing them about the closure of the infringement procedure taken against them for failure to meet certain obligations related to their marketing authorisations.